News Room

As scientists race to test coronavirus vaccines in humans, a parallel scramble is underway to produce billions of medical-grade vials and syringes that will be needed to inoculate the world’s population. The job of delivering a vaccine to a majority of humans is so vast that global production of pharmaceutical vials needs to be ramped up by 5 to 10 percent within two years, a job the industry says requires immediate preparation and increases in production but is not an
insurmountable challenge. 

Jen Cohen is about as earnest, enthusiastic and successful an athletics director as there is in the ruthless world of big-time college sports. As a Tacoma kid, she grew up enthralled by University of Washington sports. Since her 2016 appointment to succeed Scott Woodward as athletics director, she’s been in her dream job.

The shortage of crucial medical supplies, especially personal protective equipment, has crippled the United States’ ability to quell the COVID-19 pandemic. At least 54,000 nursing home residents and workers have died from COVID-19 in the U.S. as of June 26. This is a staggering number when compared to nursing homes in Hong Kong, which have reported zero deaths despite cramped quarters.

Will you be getting a vaccine in the fall? We're not talking about the vaccine you think we are, of course. The most important vaccine that every person should get is for seasonal influenza. 

From Amazon to Alibaba, the world’s top online marketplaces sell about $2 trillion in third-party products a year, generating sizeable profits just by opening their websites to other vendors. But many marketplace-style websites may be leaving cash on the table because of how they’re charging vendors to sell their goods online.